Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 373 entries
Sorted by: Best Match Show Resources per page
THE ANTIGENIC RELATIONSHIP BETWEEN PROTEUS X-19 AND TYPHUS RICKETTSIAE : A STUDY OF THE WEIL-FELIX REACTION.

The Journal of experimental medicine

Castaneda MR, Zia S.
PMID: 19870181
J Exp Med. 1933 Jun 30;58(1):55-62. doi: 10.1084/jem.58.1.55.

1. The absorption of typhus sera (human or antityphus horse serum) with Proteus X-19 removes only the Proteus agglutinins, leaving the Rickettsia agglutinins intact. 2. The absorption of typhus sera with Mexican Rickettsiae removes the agglutinins for both the...

Cite
Castaneda MR, Zia S. THE ANTIGENIC RELATIONSHIP BETWEEN PROTEUS X-19 AND TYPHUS RICKETTSIAE : A STUDY OF THE WEIL-FELIX REACTION. J Exp Med. 1933;58(1):55-62doi: 10.1084/jem.58.1.55.
Castaneda, M. R., & Zia, S. (1933). THE ANTIGENIC RELATIONSHIP BETWEEN PROTEUS X-19 AND TYPHUS RICKETTSIAE : A STUDY OF THE WEIL-FELIX REACTION. The Journal of experimental medicine, 58(1), 55-62. https://doi.org/10.1084/jem.58.1.55
Castaneda, M R, and Zia, S. "THE ANTIGENIC RELATIONSHIP BETWEEN PROTEUS X-19 AND TYPHUS RICKETTSIAE : A STUDY OF THE WEIL-FELIX REACTION." The Journal of experimental medicine vol. 58,1 (1933): 55-62. doi: https://doi.org/10.1084/jem.58.1.55
Castaneda MR, Zia S. THE ANTIGENIC RELATIONSHIP BETWEEN PROTEUS X-19 AND TYPHUS RICKETTSIAE : A STUDY OF THE WEIL-FELIX REACTION. J Exp Med. 1933 Jun 30;58(1):55-62. doi: 10.1084/jem.58.1.55. PMID: 19870181; PMCID: PMC2132277.
Copy Download .nbib Format: NLM
Basal cell carcinoma with spontaneous regression: a case report and immunohistochemical study.

Case reports in dermatology

Fujimura T, Kakizaki A, Kambayashi Y, Aiba S.
PMID: 22740815
Case Rep Dermatol. 2012 May;4(2):125-32. doi: 10.1159/000339621. Epub 2012 Jun 05.

Spontaneous regression of basal cell carcinoma (BCC) is rare, and characterized by various tumor-infiltrating lymphocytes (TILs) in the tumor. A previous report suggested that these infiltrated lymphocytes consist of type 1 helper T cells, but no detailed phenotypical analysis...

Cite
Fujimura T, Kakizaki A, Kambayashi Y, et al. Basal cell carcinoma with spontaneous regression: a case report and immunohistochemical study. Case Rep Dermatol. 2012;4(2):125-32doi: 10.1159/000339621.
Fujimura, T., Kakizaki, A., Kambayashi, Y., & Aiba, S. (2012). Basal cell carcinoma with spontaneous regression: a case report and immunohistochemical study. Case reports in dermatology, 4(2), 125-32. https://doi.org/10.1159/000339621
Fujimura, Taku, et al. "Basal cell carcinoma with spontaneous regression: a case report and immunohistochemical study." Case reports in dermatology vol. 4,2 (2012): 125-32. doi: https://doi.org/10.1159/000339621
Fujimura T, Kakizaki A, Kambayashi Y, Aiba S. Basal cell carcinoma with spontaneous regression: a case report and immunohistochemical study. Case Rep Dermatol. 2012 May;4(2):125-32. doi: 10.1159/000339621. Epub 2012 Jun 05. PMID: 22740815; PMCID: PMC3383308.
Copy Download .nbib Format: NLM
Simple pain relief score by observers (PRSO) for assessing chronic pain.

Journal of anesthesia

Aida S, Tomita M, Lee C, Fukuda S, Shimoji K.
PMID: 23839679
J Anesth. 1997 Jun;11(2):100-4. doi: 10.1007/BF02480069.

In 56 patients with severe chronic pain, pain relief was evaluated by observation of changes in activities of daily life (ADL), drug intake, and patients' mood. The degree of pain relief was scored on the basis of these evaluations...

Cite
Aida S, Tomita M, Lee C, et al. Simple pain relief score by observers (PRSO) for assessing chronic pain. J Anesth. 1997;11(2):100-4doi: 10.1007/BF02480069.
Aida, S., Tomita, M., Lee, C., Fukuda, S., & Shimoji, K. (1997). Simple pain relief score by observers (PRSO) for assessing chronic pain. Journal of anesthesia, 11(2), 100-4. https://doi.org/10.1007/BF02480069
Aida, S, et al. "Simple pain relief score by observers (PRSO) for assessing chronic pain." Journal of anesthesia vol. 11,2 (1997): 100-4. doi: https://doi.org/10.1007/BF02480069
Aida S, Tomita M, Lee C, Fukuda S, Shimoji K. Simple pain relief score by observers (PRSO) for assessing chronic pain. J Anesth. 1997 Jun;11(2):100-4. doi: 10.1007/BF02480069. PMID: 23839679.
Copy Download .nbib Format: NLM
Bacteremia following scaling and root planing: A clinico-microbiological study.

Journal of Indian Society of Periodontology

Waghmare AS, Vhanmane PB, Savitha B, Chawla RL, Bagde HS.
PMID: 24554880
J Indian Soc Periodontol. 2013 Nov;17(6):725-30. doi: 10.4103/0972-124X.124480.

BACKGROUND: Bacteremia frequently occurs after treatment procedures such as extractions, scaling, root planing, periodontal surgery. There is currently significant interest in the possibility that bacteremia with oral bacteria may play role in pathogenesis of atherosclerosis. There are well-conducted studies...

Cite
Waghmare AS, Vhanmane PB, Savitha B, et al. Bacteremia following scaling and root planing: A clinico-microbiological study. J Indian Soc Periodontol. 2013;17(6):725-30doi: 10.4103/0972-124X.124480.
Waghmare, A. S., Vhanmane, P. B., Savitha, B., Chawla, R. L., & Bagde, H. S. (2013). Bacteremia following scaling and root planing: A clinico-microbiological study. Journal of Indian Society of Periodontology, 17(6), 725-30. https://doi.org/10.4103/0972-124X.124480
Waghmare, Alka S, et al. "Bacteremia following scaling and root planing: A clinico-microbiological study." Journal of Indian Society of Periodontology vol. 17,6 (2013): 725-30. doi: https://doi.org/10.4103/0972-124X.124480
Waghmare AS, Vhanmane PB, Savitha B, Chawla RL, Bagde HS. Bacteremia following scaling and root planing: A clinico-microbiological study. J Indian Soc Periodontol. 2013 Nov;17(6):725-30. doi: 10.4103/0972-124X.124480. PMID: 24554880; PMCID: PMC3917200.
Copy Download .nbib Format: NLM
Dermoscopy findings of pseudolymphomatous folliculitis.

Case reports in dermatology

Fujimura T, Hidaka T, Hashimoto A, Aiba S.
PMID: 22807900
Case Rep Dermatol. 2012 May;4(2):154-7. doi: 10.1159/000341194. Epub 2012 Jul 12.

Pseudolymphomatous folliculitis (PLF), which clinically mimicks cutaneous lymphoma, is a rare manifestation of cutaneous pseudolymphoma and cutaneous lymphoid hyperplasia. Here, we report on a 45-year-old Japanese woman with PLF. Dermoscopy findings revealed prominent arborizing vessels with small perifollicular and...

Cite
Fujimura T, Hidaka T, Hashimoto A, et al. Dermoscopy findings of pseudolymphomatous folliculitis. Case Rep Dermatol. 2012;4(2):154-7doi: 10.1159/000341194.
Fujimura, T., Hidaka, T., Hashimoto, A., & Aiba, S. (2012). Dermoscopy findings of pseudolymphomatous folliculitis. Case reports in dermatology, 4(2), 154-7. https://doi.org/10.1159/000341194
Fujimura, Taku, et al. "Dermoscopy findings of pseudolymphomatous folliculitis." Case reports in dermatology vol. 4,2 (2012): 154-7. doi: https://doi.org/10.1159/000341194
Fujimura T, Hidaka T, Hashimoto A, Aiba S. Dermoscopy findings of pseudolymphomatous folliculitis. Case Rep Dermatol. 2012 May;4(2):154-7. doi: 10.1159/000341194. Epub 2012 Jul 12. PMID: 22807900; PMCID: PMC3398085.
Copy Download .nbib Format: NLM
Successful treatment of cutaneous botryomycosis with a combination of minocycline and topical heat therapy.

Case reports in dermatology

Ishibashi M, Numata Y, Tagami H, Aiba S.
PMID: 22679424
Case Rep Dermatol. 2012 May;4(2):114-8. doi: 10.1159/000338798. Epub 2012 May 10.

Cutaneous botryomycosis is a chronic focal infection characterized by a granulomatous inflammatory response to bacterial pathogens such as Staphylococcus aureus. Treatment requires antibiotic therapy and may also require surgical debridement. We employed topical heat therapy and oral minocycline. The...

Cite
Ishibashi M, Numata Y, Tagami H, et al. Successful treatment of cutaneous botryomycosis with a combination of minocycline and topical heat therapy. Case Rep Dermatol. 2012;4(2):114-8doi: 10.1159/000338798.
Ishibashi, M., Numata, Y., Tagami, H., & Aiba, S. (2012). Successful treatment of cutaneous botryomycosis with a combination of minocycline and topical heat therapy. Case reports in dermatology, 4(2), 114-8. https://doi.org/10.1159/000338798
Ishibashi, Masaya, et al. "Successful treatment of cutaneous botryomycosis with a combination of minocycline and topical heat therapy." Case reports in dermatology vol. 4,2 (2012): 114-8. doi: https://doi.org/10.1159/000338798
Ishibashi M, Numata Y, Tagami H, Aiba S. Successful treatment of cutaneous botryomycosis with a combination of minocycline and topical heat therapy. Case Rep Dermatol. 2012 May;4(2):114-8. doi: 10.1159/000338798. Epub 2012 May 10. PMID: 22679424; PMCID: PMC3369419.
Copy Download .nbib Format: NLM
Basosquamous cell carcinoma developing from a renal transplantation recipient.

Case reports in dermatology

Tsukada A, Fujimura T, Furudate S, Kambayashi Y, Hashimoto A, Aiba S.
PMID: 23185157
Case Rep Dermatol. 2012 Sep;4(3):227-32. doi: 10.1159/000345095. Epub 2012 Oct 24.

We describe a case of basosquamous cell carcinoma arising from a 52-year-old Japanese renal transplantation recipient (RTR). In the present case, we investigated the immunohistochemical profiles of tumor-infiltrating lymphocytes, focusing on cytotoxic granules, granulysin-bearing cells and immunosuppressive cells, such...

Cite
Tsukada A, Fujimura T, Furudate S, et al. Basosquamous cell carcinoma developing from a renal transplantation recipient. Case Rep Dermatol. 2012;4(3):227-32doi: 10.1159/000345095.
Tsukada, A., Fujimura, T., Furudate, S., Kambayashi, Y., Hashimoto, A., & Aiba, S. (2012). Basosquamous cell carcinoma developing from a renal transplantation recipient. Case reports in dermatology, 4(3), 227-32. https://doi.org/10.1159/000345095
Tsukada, Akira, et al. "Basosquamous cell carcinoma developing from a renal transplantation recipient." Case reports in dermatology vol. 4,3 (2012): 227-32. doi: https://doi.org/10.1159/000345095
Tsukada A, Fujimura T, Furudate S, Kambayashi Y, Hashimoto A, Aiba S. Basosquamous cell carcinoma developing from a renal transplantation recipient. Case Rep Dermatol. 2012 Sep;4(3):227-32. doi: 10.1159/000345095. Epub 2012 Oct 24. PMID: 23185157; PMCID: PMC3506065.
Copy Download .nbib Format: NLM
Physical activity is not related to performance at school-reply.

Archives of pediatrics & adolescent medicine

Singh AS, Uijtdewilligen L, Twisk JW, van Mechelen W, Chinapaw MJ.
PMID: 23753942
Arch Pediatr Adolesc Med. 2012 Jul 01;166(7):678-9. doi: 10.1001/archpediatrics.2012.337.

No abstract available.

Cite
Singh AS, Uijtdewilligen L, Twisk JW, et al. Physical activity is not related to performance at school-reply. Arch Pediatr Adolesc Med. 2012;166(7):678-9doi: 10.1001/archpediatrics.2012.337.
Singh, A. S., Uijtdewilligen, L., Twisk, J. W., van Mechelen, W., & Chinapaw, M. J. (2012). Physical activity is not related to performance at school-reply. Archives of pediatrics & adolescent medicine, 166(7), 678-9. https://doi.org/10.1001/archpediatrics.2012.337
Singh, Amika S, et al. "Physical activity is not related to performance at school-reply." Archives of pediatrics & adolescent medicine vol. 166,7 (2012): 678-9. doi: https://doi.org/10.1001/archpediatrics.2012.337
Singh AS, Uijtdewilligen L, Twisk JW, van Mechelen W, Chinapaw MJ. Physical activity is not related to performance at school-reply. Arch Pediatr Adolesc Med. 2012 Jul 01;166(7):678-9. doi: 10.1001/archpediatrics.2012.337. PMID: 23753942.
Copy Download .nbib Format: NLM
Tumor-Associated Macrophages: Therapeutic Targets for Skin Cancer.

Frontiers in oncology

Fujimura T, Kambayashi Y, Fujisawa Y, Hidaka T, Aiba S, Bober SL.
PMID: 29410946
Front Oncol. 2018 Jan 23;8:3. doi: 10.3389/fonc.2018.00003. eCollection 2018.

Tumor-associated macrophages (TAMs) and regulatory T cells (Tregs) are significant components of the microenvironment of solid tumors in the majority of cancers. TAMs sequentially develop from monocytes into functional macrophages. In each differentiation stage, TAMs obtain various immunosuppressive functions...

Cite
Fujimura T, Kambayashi Y, Fujisawa Y, et al. Tumor-Associated Macrophages: Therapeutic Targets for Skin Cancer. Front Oncol. 2018;8:3doi: 10.3389/fonc.2018.00003.
Fujimura, T., Kambayashi, Y., Fujisawa, Y., Hidaka, T., Aiba, S., & Bober, S. L. (2018). Tumor-Associated Macrophages: Therapeutic Targets for Skin Cancer. Frontiers in oncology, 83. https://doi.org/10.3389/fonc.2018.00003
Fujimura, Taku, et al. "Tumor-Associated Macrophages: Therapeutic Targets for Skin Cancer." Frontiers in oncology vol. 8 (2018): 3. doi: https://doi.org/10.3389/fonc.2018.00003
Fujimura T, Kambayashi Y, Fujisawa Y, Hidaka T, Aiba S, Bober SL. Tumor-Associated Macrophages: Therapeutic Targets for Skin Cancer. Front Oncol. 2018 Jan 23;8:3. doi: 10.3389/fonc.2018.00003. eCollection 2018. PMID: 29410946; PMCID: PMC5787130.
Copy Download .nbib Format: NLM
Extracellular Vesicles Transfer the Receptor Programmed Death-1 in Rheumatoid Arthritis.

Frontiers in immunology

Greisen SR, Yan Y, Hansen AS, Venø MT, Nyengaard JR, Moestrup SK, Hvid M, Freeman GJ, Kjems J, Deleuran B.
PMID: 28791012
Front Immunol. 2017 Jul 24;8:851. doi: 10.3389/fimmu.2017.00851. eCollection 2017.

INTRODUCTION: Extracellular vesicles (EVs) have been recognized as route of communication in the microenvironment. They transfer proteins and microRNAs (miRNAs) between cells, and possess immunoregulatory properties. However, their role in immune-mediated diseases remains to be elucidated. We hypothesized a...

Cite
Greisen SR, Yan Y, Hansen AS, et al. Extracellular Vesicles Transfer the Receptor Programmed Death-1 in Rheumatoid Arthritis. Front Immunol. 2017;8:851doi: 10.3389/fimmu.2017.00851.
Greisen, S. R., Yan, Y., Hansen, A. S., Venø, M. T., Nyengaard, J. R., Moestrup, S. K., Hvid, M., Freeman, G. J., Kjems, J., & Deleuran, B. (2017). Extracellular Vesicles Transfer the Receptor Programmed Death-1 in Rheumatoid Arthritis. Frontiers in immunology, 8851. https://doi.org/10.3389/fimmu.2017.00851
Greisen, Stinne R, et al. "Extracellular Vesicles Transfer the Receptor Programmed Death-1 in Rheumatoid Arthritis." Frontiers in immunology vol. 8 (2017): 851. doi: https://doi.org/10.3389/fimmu.2017.00851
Greisen SR, Yan Y, Hansen AS, Venø MT, Nyengaard JR, Moestrup SK, Hvid M, Freeman GJ, Kjems J, Deleuran B. Extracellular Vesicles Transfer the Receptor Programmed Death-1 in Rheumatoid Arthritis. Front Immunol. 2017 Jul 24;8:851. doi: 10.3389/fimmu.2017.00851. eCollection 2017. PMID: 28791012; PMCID: PMC5522841.
Copy Download .nbib Format: NLM
Serum levels of soluble CD163 and CXCL5 may be predictive markers for immune-related adverse events in patients with advanced melanoma treated with nivolumab: a pilot study.

Oncotarget

Fujimura T, Sato Y, Tanita K, Kambayashi Y, Otsuka A, Fujisawa Y, Yoshino K, Matsushita S, Funakoshi T, Hata H, Yamamoto Y, Uchi H, Nonomura Y, Tanaka R, Aoki M, Imafuku K, Okuhira H, Furudate S, Hidaka T, Aiba S.
PMID: 29643991
Oncotarget. 2018 Feb 15;9(21):15542-15551. doi: 10.18632/oncotarget.24509. eCollection 2018 Mar 20.

Antibodies against PD-1, such as nivolumab and pembrolizumab, are widely used in the treatment of various cancers including advanced melanoma. The anti-PD-1 Ab significantly prolongs survival in patients with metastatic melanoma, and its administration in combination with local or...

Cite
Fujimura T, Sato Y, Tanita K, et al. Serum levels of soluble CD163 and CXCL5 may be predictive markers for immune-related adverse events in patients with advanced melanoma treated with nivolumab: a pilot study. Oncotarget. 2018;9(21):15542-15551doi: 10.18632/oncotarget.24509.
Fujimura, T., Sato, Y., Tanita, K., Kambayashi, Y., Otsuka, A., Fujisawa, Y., Yoshino, K., Matsushita, S., Funakoshi, T., Hata, H., Yamamoto, Y., Uchi, H., Nonomura, Y., Tanaka, R., Aoki, M., Imafuku, K., Okuhira, H., Furudate, S., Hidaka, T., & Aiba, S. (2018). Serum levels of soluble CD163 and CXCL5 may be predictive markers for immune-related adverse events in patients with advanced melanoma treated with nivolumab: a pilot study. Oncotarget, 9(21), 15542-15551. https://doi.org/10.18632/oncotarget.24509
Fujimura, Taku, et al. "Serum levels of soluble CD163 and CXCL5 may be predictive markers for immune-related adverse events in patients with advanced melanoma treated with nivolumab: a pilot study." Oncotarget vol. 9,21 (2018): 15542-15551. doi: https://doi.org/10.18632/oncotarget.24509
Fujimura T, Sato Y, Tanita K, Kambayashi Y, Otsuka A, Fujisawa Y, Yoshino K, Matsushita S, Funakoshi T, Hata H, Yamamoto Y, Uchi H, Nonomura Y, Tanaka R, Aoki M, Imafuku K, Okuhira H, Furudate S, Hidaka T, Aiba S. Serum levels of soluble CD163 and CXCL5 may be predictive markers for immune-related adverse events in patients with advanced melanoma treated with nivolumab: a pilot study. Oncotarget. 2018 Feb 15;9(21):15542-15551. doi: 10.18632/oncotarget.24509. eCollection 2018 Mar 20. PMID: 29643991; PMCID: PMC5884646.
Copy Download .nbib Format: NLM
Intensity-Modulated Radiotherapy Triggers Onset of Bullous Pemphigoid in a Patient with Advanced Melanoma Treated with Nivolumab.

Case reports in oncology

Tanita K, Fujimura T, Kambayashi Y, Tsukada A, Sato Y, Hashimoto A, Aiba S.
PMID: 29606949
Case Rep Oncol. 2018 Feb 15;11(1):114-118. doi: 10.1159/000487127. eCollection 2018.

Since the efficacy of ipilimumab on nivolumab-resistant advanced melanoma is extremely low, additional supportive therapy for anti-PD-1 antibody therapy-resistant advanced melanoma is needed. Although several supportive therapies that enhance the antitumor immune response of anti-PD-1 antibodies have already been...

Cite
Tanita K, Fujimura T, Kambayashi Y, et al. Intensity-Modulated Radiotherapy Triggers Onset of Bullous Pemphigoid in a Patient with Advanced Melanoma Treated with Nivolumab. Case Rep Oncol. 2018;11(1):114-118doi: 10.1159/000487127.
Tanita, K., Fujimura, T., Kambayashi, Y., Tsukada, A., Sato, Y., Hashimoto, A., & Aiba, S. (2018). Intensity-Modulated Radiotherapy Triggers Onset of Bullous Pemphigoid in a Patient with Advanced Melanoma Treated with Nivolumab. Case reports in oncology, 11(1), 114-118. https://doi.org/10.1159/000487127
Tanita, Kayo, et al. "Intensity-Modulated Radiotherapy Triggers Onset of Bullous Pemphigoid in a Patient with Advanced Melanoma Treated with Nivolumab." Case reports in oncology vol. 11,1 (2018): 114-118. doi: https://doi.org/10.1159/000487127
Tanita K, Fujimura T, Kambayashi Y, Tsukada A, Sato Y, Hashimoto A, Aiba S. Intensity-Modulated Radiotherapy Triggers Onset of Bullous Pemphigoid in a Patient with Advanced Melanoma Treated with Nivolumab. Case Rep Oncol. 2018 Feb 15;11(1):114-118. doi: 10.1159/000487127. eCollection 2018. PMID: 29606949; PMCID: PMC5869583.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 373 entries